系列LGE-CMR与FDG-PET均阴性仍经心内膜活检确诊心脏结节病一例
本文报告一名42岁日本男性,患眼与肺结节病,系列心脏磁共振晚期钆增强(LGE-CMR)及18F-氟脱氧葡萄糖正电子发射断层(FDG-PET)检查均阴性,最终经心内膜心肌活检(EMB)确诊心脏结节病(CS)。作者指出这是首例系列LGE-CMR与FDG-PET均阴性仍确诊CS的报道,提示影像阴性不能排除CS。
要点
- 系列LGE-CMR与FDG-PET均阴性仍不能排除心脏结节病。
- 心内膜心肌活检(EMB)可在此类影像阴性病例中确立诊断。
- 系统性结节病患者中CS仅约5%,但尸检可达50%,易被漏诊。
核心结论
- 系列LGE-CMR与FDG-PET检查均阴性时仍可能经EMB确诊心脏结节病。
研究设计与样本
- 单例病例报告:42岁日本男性,患眼与肺结节病。
主要发现
- 系列LGE-CMR与FDG-PET均阴性,最终经EMB确诊CS。
- 作者称这是首例系列LGE-CMR与FDG-PET均阴性仍诊断CS的报道。
- 系统性结节病患者中CS仅占5%,致命性结节病尸检系列中CS可达50%。
关键数值与推荐
- 系统性结节病患者中CS发生率为5%。
- 致命性结节病尸检系列中CS发现率高达50%。
临床怎么用
- 对高度怀疑CS但系列LGE-CMR与FDG-PET阴性的患者,应考虑EMB以明确诊断。
局限性
- 本文为单例病例报告,结论不能外推为普遍诊断策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present a case of a 42-year-old Japanese man with ocular and pulmonary sarcoidosis who eventually led to a diagnosis with cardiac sarcoidosis (CS) through endomyocardial biopsy (EMB), despite negative findings on both late gadolinium enhancement with cardiac magnetic resonance (LGE-CMR) imaging and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Cardiac sarcoidosis (CS) develops in only 5% of patients with systemic sarcoidosis. Previous studies have reported that CS was found in up to 50% of autopsy series with fatal sarcoidosis, implying that CS is frequently underdiagnosed with potentially life-threatening consequences. Therefore, the diagnostic accuracy and prognostic value of CS are important. Currently, LGE-CMR and FDG-PET play an important role in establishing a diagnosis of CS with high sensitivity. In the presented case, regardless of serial examinations with LGE-CMR and FDG-PET, confirmed diagnosis of CS could not be achieved; ultimately, a definitive diagnosis of CS was obtained through EMB. To the best of our knowledge, this is the first reported case showing the diagnosis of CS despite negative findings on serial LGE-CMR and FDG-PET examinations.
引用
- Tanaka TD, Nagai T, Nagoshi T, et al. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/18F-fluorodeoxyglucose positron emission tomography examinations. J Nucl Cardiol. 2019. PMID: 31773564. doi:10.1007/s12350-019-01968-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。